Drug Shortage Report for MYLAN-BECLO AQ
Report ID | 80428 |
Drug Identification Number | 02172712 |
Brand name | MYLAN-BECLO AQ |
Common or Proper name | BECLO AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
Strength(s) | 50MCG |
Dosage form(s) | METERED-DOSE AEROSOL SUSPENSION |
Route of administration | NASAL |
Packaging size | 22s |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-05 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.